Viewing Study NCT04814069

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 10:46 PM

Ignite Modification Date: 2025-12-25 @ 8:16 PM

Study NCT ID: NCT04814069

Status: UNKNOWN

Last Update Posted: 2021-03-24

First Post: 2021-03-23

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A Multicenter Phase II Trial of Post-operative Concurrent Chemoradiotherapy Using Weekly Cisplatin With Tislelizumab for Patients With High-risk Head and Neck Squamous Cell Carcinoma：The POTENTIAL Study

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module